TransCode Therapeutics In... (RNAZ)

NASDAQ: RNAZ · Real-Time Price · USD

0.51

-0.05 (-9.57%)

At close: May 02, 2025, 3:59 PM

TransCode Therapeutics Stock Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for RNAZ stock have an median target of 10, with a low estimate of 10 and a high estimate of 10. The median target predicts an increase of 1860.78% from the current stock price of 0.51.

Target	Low	Average	Median	High
Price	$10	$10	$10	$10
Change	1860.78%	1860.78%	1860.78%	1860.78%

Latest Analyst Insight Report

HC Wainwright & Co. has reaffirmed a Buy rating fo... Unlock content with Pro Subscription

Updated Apr 16, 2025

Rating	Oct 24	Nov 24	Dec 24	Feb 25	Mar 25	Apr 25
Strong Buy	0	0	1	0	0	0
Buy	1	1	0	2	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	2	1	1

Financial Forecast this Year

Revenue This Year

300K

from 0

Revenue Next Year

from 300K

233.3%

from 300K

EPS This Year

-157.08

from -103.61

-51.6%

from -103.61

EPS Next Year

-144.21

from -157.08

8.2%

from -157.08